相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder
Livia Maria Bolsoni et al.
PSYCHOPHARMACOLOGY (2022)
A placebo-controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans
Caroline A. Arout et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial
Jonathan Vela et al.
PAIN (2022)
Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters
Jose A. Crippa et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2022)
The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event
Livia Maria Bolsoni et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2022)
Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function
Kieran Shay Struebin Abbotts et al.
NUTRIENTS (2022)
Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years
Sara L. MacPhail et al.
FRONTIERS IN PHARMACOLOGY (2022)
Effects of Cannabidiol on Exercise Physiology and Bioenergetics: A Randomised Controlled Pilot Trial
Ayshe Sahinovic et al.
SPORTS MEDICINE-OPEN (2022)
Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical Trial
Paul B. Watkins et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
The Effects of Cannabidiol Oil on Noninvasive Measures of Muscle Damage in Men
Kristen C. Cochrane-Snyman et al.
MEDICINE & SCIENCE IN SPORTS & EXERCISE (2021)
Comparison of Five Oral Cannabidiol Preparations in Adult Humans: Pharmacokinetics, Body Composition, and Heart Rate Variability
Natasha N. Bondareva Williams et al.
PHARMACEUTICALS (2021)
A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor
Stela Santos de Alencar et al.
PARKINSONISM & RELATED DISORDERS (2021)
Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
Carolina de Meneses-Gaya et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2021)
Cannabidiol as a Treatment for Mental Health Outcomes Among Health Care Workers During the Coronavirus Disease Pandemic
Julia Cozar Pacheco et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2021)
The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain
Bronwyn Bebee et al.
MEDICAL JOURNAL OF AUSTRALIA (2021)
Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study
Orrin Devinsky et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Effects of Cannabidiol Supplementation on Skeletal Muscle Regeneration after Intensive Resistance Training
Eduard Isenmann et al.
NUTRIENTS (2021)
A primer on medicinal cannabis safety and potential adverse effects
Jonathon C Arnold
Australian Journal of General Practice (2021)
Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic A Randomized Clinical Trial
Jose Alexandre S. Crippa et al.
JAMA NETWORK OPEN (2021)
Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis
Tory R. Spindle et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2020)
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
Jerome Sarris et al.
BMC PSYCHIATRY (2020)
A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment
Bola Tayo et al.
CLINICAL PHARMACOKINETICS (2020)
An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care
Phillip D. Good et al.
JOURNAL OF PALLIATIVE MEDICINE (2020)
Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease
Stephanie Martins de Faria et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
A Phase 1, Randomised, Placebo-Controlled, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Cannabidiol in Fed Healthy Volunteers
Daniel Perkins et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2020)
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
Rafael G. Dos Santos et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2020)
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
Edward Chesney et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Evaluation of pharmacokinetics and acute anti-inflammatory potential of two oral cannabidiol preparations in healthy adults
Jack M. Hobbs et al.
PHYTOTHERAPY RESEARCH (2020)
Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users
Tory R. Spindle et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers
Dvora Izgelov et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Therapeutic Efficacy of Cannabidiol (CBD): a Review of the Evidence From Clinical Trials and Human Laboratory Studies
Dennis J. Sholler et al.
CURRENT ADDICTION REPORTS (2020)
Access to cannabidiol without a prescription: A cross-country comparison and analysis
Iain S. McGregor et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2020)
Oral Cannabidiol Does Not Convert to Δ8-THC or Δ9-THC in Humans: A Pharmacokinetic Study in Healthy Subjects
Jose Alexandre S. Crippa et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Prescribing medicinal cannabis
Jonathon C. Arnold et al.
AUSTRALIAN PRESCRIBER (2020)
The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review
C. Hindocha et al.
JOURNAL OF DUAL DIAGNOSIS (2020)
Effects of Hemp Extract on Markers of Wellness, Stress Resilience, Recovery and Clinical Biomarkers of Safety in Overweight, But Otherwise Healthy Subjects
Hector L. Lopez et al.
JOURNAL OF DIETARY SUPPLEMENTS (2020)
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Tom P. Freeman et al.
LANCET PSYCHIATRY (2020)
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
C. Michael White
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
A Phase 1, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment
Lesley Taylor et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
Yasmin L. Hurd et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
Yann Chye et al.
FRONTIERS IN PSYCHIATRY (2019)
A systematic review of cannabidiol dosing in clinical populations
S. A. Millar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy
Angela K. Birnbaum et al.
EPILEPSIA (2019)
A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects
Katharina Knaub et al.
MOLECULES (2019)
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Stefania Bonaccorso et al.
NEUROTOXICOLOGY (2019)
Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use
Paulo Fleury-Teixeira et al.
FRONTIERS IN NEUROLOGY (2019)
Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
Ila M. Linares et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2019)
Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review
Jasmine Turna et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2019)
A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects
Gilmour Morrison et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications
Yuli Qian et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
Philip McGuire et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle
Gustavo Gonzalez-Cuevas et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey
Emily A. Karanges et al.
BMJ OPEN (2018)
No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Ila M. P. Linares et al.
FRONTIERS IN PHARMACOLOGY (2018)
Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats
Gracie L. Hay et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor et al.
CNS DRUGS (2018)
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
Sophie A. Millar et al.
FRONTIERS IN PHARMACOLOGY (2018)
Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial
Nadia Solowij et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets Technology
Jacob Atsmon et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2018)
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
Antonio W. Zuardi et al.
Frontiers in Pharmacology (2017)
Cannabidiol Does Not Dampen Responses to Emotional Stimuli in Healthy Adults
David L. Arndt et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial
Timna Naftali et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
Kerstin Iffland et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
Margaret Haney et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
Khalid A. Jadoon et al.
DIABETES CARE (2016)
Paroxetine, Cognitive Therapy or Their Combination in the Treatment of Social Anxiety Disorder with and without Avoidant Personality Disorder: A Randomized Clinical Trial
Hans M. Nordahl et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2016)
Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study
Moshe Yeshurun et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Safety and Pharmacokinetics of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl in Humans
Alex F. Manini et al.
JOURNAL OF ADDICTION MEDICINE (2015)
Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
Matthew W. Elmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Molecular Targets of Cannabidiol in Neurological Disorders
Clementino Ibeas Bih et al.
NEUROTHERAPEUTICS (2015)
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
M. H. N. Chagas et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Effects of cannabidiol in the treatment of patients with Parkinson's disease: An exploratory double-blind trial
Marcos Hortes N. Chagas et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
The weight of nations: an estimation of adult human biomass
Sarah Catherine Walpole et al.
BMC PUBLIC HEALTH (2012)
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
Jose Alexandre S. Crippa et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)
Jaime E. C. Hallak et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2010)
Cannabidiol for the treatment of psychosis in Parkinson's disease
A. W. Zuardi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Effects of cannabidiol (CBD) on regional cerebral blood flow
JAD Crippa et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 'N of 1' studies
W Notcutt et al.
ANAESTHESIA (2004)
分享论文
